Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Negrin

Showing results (221-230 of 260) with videos related to

Pageof 26
Sort By:
Transplantation and Cellular Therapy|April 29, 2021
Stem Cell Mobilization in Multiple Myeloma: Comparing Safety and Efficacy of Cyclophosphamide +/- Plerixafor versus Granulocyte Colony-Stimulating Factor +/- Plerixafor in the Lenalidomide EraAndrew Johnsrud, Abdullah Ladha, Lori Muffly, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 20, 2011
Long-term outcome of patients with metastatic breast cancer treated with high-dose chemotherapy and transplantation of purified autologous hematopoietic stem cellsAntonia M S Müller, Holbrook E K Kohrt, Steven Cha, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 21, 2017
Increased Foxp3<sup>+</sup>Helios<sup>+</sup> Regulatory T Cells and Decreased Acute Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation in Patients Receiving Sirolimus and RGI-2001, an Activator of Invariant Natural Killer T CellsYi-Bin Chen, Yvonne A Efebera, Laura Johnston, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 1998
Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignanciesG D Long, M D Amylon, K E Stockerl-Goldstein, et al.
Nature Communications|May 31, 2014
Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerancePatricia E de Almeida, Everett H Meyer, Nigel G Kooreman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 1, 1996
Paradoxical effect of thalidomide prophylaxis on chronic graft-vs.-host diseaseN J Chao, P M Parker, J C Niland, et al.
Bone Marrow Transplantation|June 24, 2021
Outcomes after delayed and second autologous stem cell transplant in patients with relapsed multiple myelomaChristopher Lemieux, Lori S Muffly, David J Iberri, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2009
Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generationAnnelie E Abrahamsson, Ifat Geron, Jason Gotlib, et al.
Blood|May 8, 2012
Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidenceSally Arai, Bita Sahaf, Balasubramanian Narasimhan, et al.
JCI Insight|March 4, 2020
MicroRNA-146a regulates immune-related adverse events caused by immune checkpoint inhibitorsDominik Marschner, Martina Falk, Nora Rebeka Javorniczky, et al.
Pageof 26

Showing results (221-230 of 260) with videos related to

Sort By:
Pageof 26
Transplantation and Cellular Therapy|April 29, 2021
Stem Cell Mobilization in Multiple Myeloma: Comparing Safety and Efficacy of Cyclophosphamide +/- Plerixafor versus Granulocyte Colony-Stimulating Factor +/- Plerixafor in the Lenalidomide EraAndrew Johnsrud, Abdullah Ladha, Lori Muffly, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 20, 2011
Long-term outcome of patients with metastatic breast cancer treated with high-dose chemotherapy and transplantation of purified autologous hematopoietic stem cellsAntonia M S Müller, Holbrook E K Kohrt, Steven Cha, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 21, 2017
Increased Foxp3<sup>+</sup>Helios<sup>+</sup> Regulatory T Cells and Decreased Acute Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation in Patients Receiving Sirolimus and RGI-2001, an Activator of Invariant Natural Killer T CellsYi-Bin Chen, Yvonne A Efebera, Laura Johnston, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 1998
Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignanciesG D Long, M D Amylon, K E Stockerl-Goldstein, et al.
Nature Communications|May 31, 2014
Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerancePatricia E de Almeida, Everett H Meyer, Nigel G Kooreman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 1, 1996
Paradoxical effect of thalidomide prophylaxis on chronic graft-vs.-host diseaseN J Chao, P M Parker, J C Niland, et al.
Bone Marrow Transplantation|June 24, 2021
Outcomes after delayed and second autologous stem cell transplant in patients with relapsed multiple myelomaChristopher Lemieux, Lori S Muffly, David J Iberri, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2009
Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generationAnnelie E Abrahamsson, Ifat Geron, Jason Gotlib, et al.
Blood|May 8, 2012
Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidenceSally Arai, Bita Sahaf, Balasubramanian Narasimhan, et al.
JCI Insight|March 4, 2020
MicroRNA-146a regulates immune-related adverse events caused by immune checkpoint inhibitorsDominik Marschner, Martina Falk, Nora Rebeka Javorniczky, et al.
Pageof 26